Gdanskie Centrum Zdrowia Sp. z o.o.

The department is investigating core nervous system disorders such as Autism spectrum disorder and Tourette Syndrome through studies that assess new therapeutic agents and their impact on social communication and tic severity.

• Improving social interaction in ASD
• Reducing tic frequency and severity
• Assessing long‑term safety of investigational drugs

At Gdanskie Centrum Zdrowia these trials aim to expand safe treatment options for young patients across Europe.

Research targets the underlying behavioral mechanisms of conditions like irritability in children with autism, exploring how novel compounds can modify mood and interaction patterns.

• Irritability management in ASD
• Behavioral response to pitolisant
• Safety monitoring in pediatric populations

The work supports the hospital’s goal to enhance quality of life for patients with neurodevelopmental challenges.

Studies focus on mental disorders including Tourette’s and autism‑related symptoms, evaluating efficacy of emerging therapies and their tolerability over extended periods.

• Long‑term tolerability of pimavanserin
• Efficacy of gemlapodect for tic reduction
• Comprehensive assessment of ASD symptom domains

Findings from these investigations contribute to a broader understanding of psychiatric care in the Polish healthcare system.